$31.29
-0.720 (-2.25%)
At Close: Jun 03, 2026
Asian Exports Are Softening
11:46am, Thursday, 01'st Sep 2022
Non-China Asian exports are still growing, but the pace of increase has slowed and will slow still further as key export destinations struggle with inflation, energy security, and rising recession ris
The Challenges Ahead For China's Economy
10:00am, Monday, 29'th Aug 2022
Chinese economy may do modestly better in the second half of 2022. Longer term, the primary headwind for the Chinese economy lies in demographic patterns.
China's Economy Has Faced Headwinds, But Are Investment Opportunities Emerging?
04:32pm, Thursday, 04'th Aug 2022
China's economy has struggled, but may be turning a corner. Why investors may want to consider Chinese stocks in their long game.
China's Stimulative Policy Actions: Turning The Tide For Investors
11:05am, Friday, 01'st Jul 2022
China's zero-COVID policy has cratered the economy, severely hampering mobility and discouraging consumer spending on services. In addition, it has extended economic uncertainty for businesses and cau
China's Economic Outlook For The Second Half Of 2022
11:13am, Wednesday, 29'th Jun 2022
China's nominal GDP reached $17.5 trillion in 2021, a growth rate of 8.1%. We expect a slower GDP growth rate in 2022 due to very tight Covid measures in Q2 of this year.
China Growth: Brighter Prospects?
01:45pm, Wednesday, 01'st Jun 2022
The latest batch of official PMI data gave a nice boost to Chinese equities and also commodities. While China's supply-side stimulus allows to “mobilize” the official sector fairly quickly, it doe
The Chinese Slowdown: Much More Than Covid
01:45pm, Saturday, 07'th May 2022
The most recent macroeconomic figures show that the Chinese slowdown is much more severe than expected and not only attributable to the Covid-19 lockdowns. It is easy to use the Covid-19 lockdowns as
iShares MSCI China Small-Cap ETF: Down But Not Out
11:51am, Wednesday, 20'th Apr 2022
Real estate accounts for the largest share in ECNS, and this segment is facing plenty of challenges. China's potential invasion of Taiwan is an underappreciated risk.
Stock Traders Purchase High Volume of Call Options on iShares MSCI China Small-Cap ETF (NYSEARCA:ECNS)
06:20am, Tuesday, 07'th Dec 2021 Dakota Financial News
iShares MSCI China Small-Cap ETF (NYSEARCA:ECNS) saw some unusual options trading on Monday. Traders acquired 5,100 call options on the stock. This is an increase of 63,650% compared to the typical volume of 8 call options. Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Parallel Advisors []
Mind The Bond Market
12:20pm, Thursday, 18'th Nov 2021
The deficit spending that supported the economy in 2020 is showing up in hot inflation numbers in 2021. While I think the inflation numbers will get better in 2022, I do not believe they will get back
China's Next Phase Can Make You Money Or Steal Your Savings
08:11am, Friday, 05'th Nov 2021
China has not solved the unravelling crisis in its development/construction sector. The nation has moved through all the ‘natural' stages an economy goes through when implementing the free market ca
Evergrande Isn't China's 'Lehman Moment.' It Could Be Worse Than That
12:09pm, Sunday, 26'th Sep 2021
The bankruptcy of the Chinese real estate company Evergrande is much more than a “Chinese Lehman”. The implications of an Evergrande collapse are far greater than what investment banks tell us.
What's The Likely End For Evergrande?
08:37am, Friday, 24'th Sep 2021
Chinese government has generally had some idea of how much risk Evergrande and other highly leveraged real estate companies pose since last year. Equity holders will most likely be wiped out, with hol
The World Sweats During China's Vacation
03:55am, Tuesday, 21'st Sep 2021
The impact of the policy remedy to China's property market excesses is spreading across global markets. But they would bounce hard on any evidence of a mitigation plan from Beijing.
ECNS: Undervalued With Fewer ADR Exposures
10:51pm, Monday, 09'th Aug 2021
ECNS: Undervalued With Fewer ADR Exposures
Sign In
Buy ECNS